UNICA IRIS Institutional Research Information System

PANI, ANTONELLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 69.593
NA - Nord America 3.847
AS - Asia 695
OC - Oceania 8
AF - Africa 6
SA - Sud America 4
Totale 74.153
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 68.786
US - Stati Uniti d'America 3.827
SE - Svezia 381
CN - Cina 371
SG - Singapore 182
UA - Ucraina 109
DE - Germania 91
FI - Finlandia 76
GB - Regno Unito 66
VN - Vietnam 64
FR - Francia 35
KR - Corea 34
CA - Canada 17
NL - Olanda 11
BE - Belgio 9
HK - Hong Kong 9
RU - Federazione Russa 8
AU - Australia 7
IN - India 7
TW - Taiwan 6
TR - Turchia 5
AE - Emirati Arabi Uniti 4
IE - Irlanda 4
PT - Portogallo 4
AT - Austria 3
BR - Brasile 3
MX - Messico 3
PK - Pakistan 3
PL - Polonia 3
ZA - Sudafrica 3
DZ - Algeria 2
HU - Ungheria 2
JP - Giappone 2
QA - Qatar 2
RO - Romania 2
SA - Arabia Saudita 2
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
BJ - Benin 1
EE - Estonia 1
ES - Italia 1
ID - Indonesia 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PH - Filippine 1
Totale 74.153
Salva come PNG Salva come JPEG
Città #
Cagliari 68.407
Fairfield 727
Nyköping 335
Woodbridge 328
Ashburn 315
Seattle 290
Houston 283
Cambridge 264
Wilmington 241
Chandler 184
Ann Arbor 146
Boardman 102
Jacksonville 94
Dearborn 92
Shanghai 83
Boston 71
Helsinki 69
Dong Ket 64
Nanjing 64
Singapore 62
Rome 47
San Diego 47
Seoul 34
Beijing 29
New York 26
Hebei 22
Jiaxing 22
Redwood City 22
Nanchang 21
London 19
Sèlegas 18
Milan 17
Changsha 14
Norwalk 13
Toronto 13
Guangzhou 12
Phoenix 12
Mountain View 11
Shenyang 11
Catania 10
Hefei 10
Redmond 10
San Mateo 9
Bologna 8
Brussels 8
Hong Kong 8
Bari 7
Jinan 7
Paris 6
Xian 6
Arezzo 5
Los Angeles 5
Naples 5
Perugia 5
Rockville 5
Selargius 5
Zhengzhou 5
Chicago 4
Frankfurt am Main 4
Kunming 4
Rochester 4
Sassari 4
Savignano sul Panaro 4
Taipei 4
Tolentino 4
Assèmini 3
Augusta 3
Borås 3
Brisbane 3
Dolianova 3
Dublin 3
Filadelfia 3
Florence 3
Garden City 3
Johannesburg 3
Laurel 3
Monserrato 3
Nürnberg 3
Padova 3
Palermo 3
Tianjin 3
Verona 3
Vienna 3
Villiers-sur-marne 3
Ìsili 3
Abu Dhabi 2
Andover 2
Arnsberg 2
Atlanta 2
Aversa 2
Barletta 2
Bitonto 2
Breganze 2
Budapest 2
Cascina 2
Chongqing 2
Council Bluffs 2
Dalmine 2
Doha 2
Fonni 2
Totale 72.877
Salva come PNG Salva come JPEG
Nome #
Overexpression of the cytokine BAFF and autoimmunity risk 3.690
Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study 3.366
Renal function during long-term lithium treatment: a cross-sectional and longitudinal study 3.289
Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: a longitudinal study 2.719
Long-term lithium and estimated glomerular filtration rate 2.663
KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation 2.635
Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes 1.882
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 1.612
Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors in a general population 1.360
Cardiorenal syndrome type 4 (CRS 4) associated with anaemia long term survival analysis 1.330
Exercise-Associated hyponatremia: 2017 update 1.297
Genome-Wide Analysis Studies and Chronic Kidney Disease 1.287
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update 1.222
Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up 1.147
Vegan-vegetarian low-protein supplemented diets in pregnant CKD patients: fifteen years of experience 1.109
Outcomes of Pregnancies after Kidney Transplantation: Lessons Learned from CKD. A Comparison of Transplanted, Nontransplanted Chronic Kidney Disease Patients and Low-Risk Pregnancies: A Multicenter Nationwide Analysis 1.102
Risk of adverse pregnancy outcomes in women with CKD 1.087
Efficiency and nutritional parameters in an elderly high risk population on hemodialysis and hemodiafiltration in Italy and France: different treatments with similar names? 1.061
A multicenter study of the predictive value of crescents in IgA nephropathy 1.017
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 1.008
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group 996
Opening an onconephrology clinic: recommendations and basic requirements 995
Treatment of primary membranous nephropathy: where are we now? 969
Multicenter study on parathyroidectomy (PTX) in Italy: preliminary results 968
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis 912
Pregnancy outcomes after kidney graft in Italy: are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013) 900
Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question) 890
Compliance, illiteracy and low-protein diet: multiple challenges in CKD and a case of self-empowerment 851
Diabetic kidney disease: A syndrome rather than a single disease 841
Patient Selection and Timing of Continuous Renal Replacement Therapy 840
Pregnancy in Chronic Kidney Disease: questions and answers in a changing panorama 777
CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations 729
Glomerular diseases and cancer: evaluation of underlying malignancy 727
Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes 726
Standardized reporting of monoclonal iImmunoglobulin-associated renal diseases: Recommendations from a Mayo Clinic/Renal Pathology Society Working Group 712
Diagnosis of complement alternative pathway disorders 704
The children of dialysis: live-born babies from on-dialysis mothers in Italy--an epidemiological perspective comparing dialysis, kidney transplantation and the overall population 698
FSGS: from pathogenesis to the histological lesion 664
Corticosteroid treatment influences TA-Proteinuria and renal survival in IgA nephropathy 646
Sodium and Volume Disorders in Advanced Chronic Kidney Disease 631
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 615
Changes in proteinuria and side effects of corticosteroids alone or in combination with azathioprine at different stages of IgA nephropathy 611
Prevalence of CKD and its relationship to eGFR-related genetic loci and clinical risk factors in the SardiNIA study cohort 551
Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study 510
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments 505
Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: Protocol of a pilot randomised controlled trial 502
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes 478
Hyperkalemia in hemodialysis patients 477
Linee guida alla prevenzione, diagnosi e terapia delle sindromi di danno renale acuto: versione italiana delle KDIGO, integrata con le nuove evidenze e i commentari internazionali = Guidelines for the prevention, diagnosis and treatment of acute kidney injury syndromes: Italian version of KDIGO, integrated with new evidence and international commentaries 472
Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy 460
PRF1 mutation alters immune system activation, inflammation, and risk of autoimmunity 440
Standard immunosuppressive therapy of immune-mediated glomerular diseases 408
Approach to Diagnosis and Treatment of Hypercalcemia in a Patient With Malignancy 396
COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France 388
Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD 369
IgA nephropathy with severe chronic renal failure: A randomized controlled trial of corticosteroids and azathioprine 355
How Genetics Can Improve Clinical Practice in Chronic Kidney Disease: From Bench to Bedside 347
Prevalence of hypertension in a large cohort of Italian hemodialysis patients: results of a cross-sectional study 337
Unexpected Outcomes of Renal Function after Radical Nephrectomy: Histology Relevance along with Clinical Aspects 331
Immunosuppressive treatment in dialysis patients 324
Chronic kidney disease of undetermined etiology around the world 323
Extensive proximal tubular necrosis without recovery following the ingestion of Amanita phalloides: a case report 320
History of Preeclampsia in Patients Undergoing a Kidney Biopsy: A Biphasic, Multiple-Hit Pathogenic Hypothesis 318
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome 315
La Nefrologia in Tasca 308
Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy 308
Tossicità renale da farmaci antineoplastici 307
The impact of the secondary infections in ICU patients affected by COVID-19 during three different phases of the SARS-CoV-2 pandemic 300
CLINICAL PRESENTATION AND OUTCOME OF PATIENTS AFFECTED BY SYSTEMIC AMYLOIDOSIS WITH PREDOMINANT RENAL INVOLVEMENT: A 10 YEAR, SINGLE CENTRE EXPERIENCE 279
DIAGNOSIS AND PREVALENCE OF NON DIABETIC RENAL DISEASES IN PATIENTS WITH DIABETES: A TWENTY YEARS EXPERIENCE 277
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy 275
Ramipril and cardiovascular outcomes in patients on maintenance hemodialysis. The ARCADIA multicenter randomized controlled trial 274
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry 270
Mediterranean spotted fever with acute renal failure stimulating a relapse in C-ANCA vasculitis 268
Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario 255
Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy 253
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease 249
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey 245
Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients 244
The role of rituximab in the treatment of ANCA-associated systemic vasculitis 240
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 240
Is renal vasculitis in patients with systemic lupus erythematosus a bad prognostic factor? 239
Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease. 238
Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? 238
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool 236
METFORMIN-ASSOCIATED LACTIC ACIDOSIS (MALA): A SINGLE CENTRE EXPERIENCE ON 14 PATIENTS 235
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial 235
Risk for chronic kidney disease in the general population Italian reports for World Kidney Days 2007-2009 234
Acute renal failure with thrombotic microangiopathy in multicentric Castleman's disease 226
[A new clinicopathological classification for IgA nephropathy (the Oxford IgA nephropathy classification)]. 223
L'utilita' delle biopsie protocollari nel trapianto di rene: pro e contro.[The usefulness of protocol biopsies after kidney transplant: pros and cons] 217
Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis 215
Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. The Italian Group of Renal Immunopathology 212
Diagnostic significance and antigen specificity of antineutrophil cytoplasmic antibodies in renal diseases: A prospective multicentre study 209
Nephrotic syndrome: new concepts in the pathophysiology of sodium retention 209
Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: Evidence from the VALidation of IGA study cohort 203
Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial 202
Acute renal failure after massive ingestion of gliclazide in a suicide attempt 198
Renal histological picture and steroid treatment in IGA nephropathy 198
RECURRENT NEPHRITIC SYNDROME WITH AN UNUSUAL CLINICAL-HISTOLOGICAL PATTERN-2 CASES. 194
Totale 70.964
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.742
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015.195 0 417 188 348 6.005 4.410 2.208 516 271 249 160 423
2020/202120.487 418 634 825 6.034 4.522 2.199 1.742 1.235 391 979 853 655
2021/20226.217 720 494 245 360 463 549 326 238 408 484 1.036 894
2022/20238.620 796 854 908 604 876 838 473 742 613 564 916 436
2023/202412.187 403 413 448 630 1.134 2.215 2.376 814 645 613 1.121 1.375
2024/20255.545 3.948 1.597 0 0 0 0 0 0 0 0 0 0
Totale 74.534